Breast Cancer Research and Treatment

Loss of BRCA1 expression in sporadic male breast carcinoma
pp. 1-7(7)
Authors: Sun X.; Gong Y.; Rao M.S.; Badve S.

Inhibition of myc-dependent breast tumor formation in transgenic mice
pp. 9-20(12)
Authors: Cui W.; Gusterson B.A.; Clark A.J.

Involvement of breast epithelial-stromal interactions in the regulation of protein tyrosine phosphatase- (PTP) mRNA expression by estrogenically active agents
pp. 21-35(15)
Authors: Liu S.; Kulp S.K.; Sugimoto Y.; Jiang J.; Chang H-l.; Lin Y.C.

Melatonin inhibits estrogen receptor transactivation and cAMP levels in breast cancer cells
pp. 37-45(9)
Authors: Kiefer T.; Ram P.T.; Yuan L.; Hill S.M.

Dominant negative interference of transcription factor AP-2 causes inhibition of ErbB-3 expression and suppresses malignant cell growth
pp. 47-57(11)
Authors: Zhu C-H.; Domann F.E.

Organochlorines, p53 mutations in relation to breast cancer risk and survival. A Danish cohort-nested case-controls study
pp. 59-65(7)
Authors: Høyer A.P.; Gerdes A-M.; Jørgensen T.; Rank F.; Bøggild Hartvig H.

Prognostic value of epidermal growth factor receptor (EGFR) and its relationship to the estrogen receptor status in 1029 patients with breast cancer
pp. 67-75(9)
Authors: Tsutsui S.; Ohno S.; Murakami S.; Hachitanda Y.; Oda S.

Overexpression of MDM2 oncoprotein correlates with possession of estrogen receptor alpha and lack of MDM2 mRNA splice variants in human breast cancer
pp. 77-84(8)
Authors: Hori M.; Shimazaki J.; Inagawa S.; Itabashi M.; Hori M.

Preservation of histopathologic assessment by use of a special technique for tissue inactivation by radiofrequency
pp. 85-88(4)
Authors: Heywang-Köbrunner S.H.; Weiwad W.; Lampe D.; Buchmann J.

Breast Cancer Research and Treatment
pp. 89-93(5)
Author: Allison J.